References
A comparison of antiarrhythmic–drug therapy with implantable defibrillators in patients resuscitated from near–fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 337(22): 1576–1583
Lee KL, Hafley G, Fisher JD et al (2002) Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 106(2):233–238
Moss AJ (2002) MADIT–II and implications for noninvasive electrophysiologic testing. Ann Noninvasive Electrocardiol 7(3):179–180
Korte T, Trappe HJ, Gronefeld G et al (2000) [A new ICD morphology criterion for differentiating supraventricular and ventricular tachycardia]. Z Kardiol 89(11):1019–1025
Schibgilla V, Nossen J, Kuhn I et al (1998) [Anti–bradycardia ventricle stimulation during the vulnerable phase of the heart cycle in ICD system with DDD cardiac pacemaker function]. Z Kardiol 87(8):640–643
Winters SL, Packer DL, Marchlinski FE et al (2001) Consensus statement on indications, guidelines for use, and recommendations for follow–up of implantable cardioverter defibrillators. North American Society of Electrophysiology and Pacing. Pacing Clin Electrophysiol 24(2):262–269
Luderitz B, Wolpert C (2003) The patient’s informed consent for pacemakers and ICD implantation: how to write and how to explain it. Z Kardiol 92(5):377–383
Volkmann H, Bergmann C, Walter M (2005) [Cardiac resynchronization therapy: who is suitable? Who requires an additional ICD as a backup?]. Z Kardiol 94(Suppl 4):IV/60–64
Gregoratos G, Cheitlin MD, Conill A et al (1998) ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary – a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 97(13):1325–1335
Hauer RN, Aliot E, Block M et al (2001) Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 22(13):1074–1081
Wallbruck K, Stellbrink C, Santini M et al (2002) The value of permanent follow–up of implantable pacemakers – first results of an European trial. Biomed Tech (Berl) 47(Suppl 1)Pt 2:950–953
Koos R, Sinha AM, Stellbrink C (2005) Home Monitoring in an ICD patient with incessant ventricular tachycardia. Z Kardiol 94(7):461–464
Fritzsche D, Eitz T, Grimmig O et al (2004) [Home monitoring of patients after prosthetic valve replacement – a new method of early detection of valve dysfunction]. Z Kardiol 93(9):664–670
Theuns DA, Res JC, Jordaens LJ (2003) Home monitoring in ICD therapy: future perspectives. Europace 5(2):139–142
Weretka S, Michaelsen J, Becker R et al (2003) Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 26(1 Pt 1):65–70
Wilkoff BL, Kuhlkamp V, Volosin K et al (2001) Critical analysis of dualchamber implantable cardioverter–defibrillator arrhythmia detection: results and technical considerations. Circulation 103(3):381–386
Fauchier L, Sadoul N, Kouakam C et al (2005) Potential cost savings by telemedicine–assisted long–term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 28(Suppl 1):S255–259
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ritter, O., Bauer, W.R. Use of “IEGM Online” in ICD patients—. Clin Res Cardiol 95, 368–372 (2006). https://doi.org/10.1007/s00392-006-0390-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-0390-y